Healthcare provider profile · identity verified

Lien P Dame, MD

Internal Medicine · ORANGE, VA · NPI 1760694475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	553	147
Amlodipine Besylate	Amlodipine Besylate	326	99
Omeprazole	Omeprazole	279	73
Lisinopril	Lisinopril	255	67
Hydrochlorothiazide	Hydrochlorothiazide	251	74
Losartan Potassium	Losartan Potassium	214	60
Levothyroxine Sodium	Levothyroxine Sodium	160	49
Albuterol Sulfate Hfa	Albuterol Sulfate	155	48
Furosemide	Furosemide	151	44
Eliquis	Apixaban	140	28
Metformin Hcl	Metformin Hcl	130	38
Gabapentin	Gabapentin	125	39
Metformin Hcl Er	Metformin Hcl	106	32
Tramadol Hcl	Tramadol Hcl	104	27
Ozempic	Semaglutide	101	21
Metoprolol Succinate	Metoprolol Succinate	98	31
Fluticasone Propionate	Fluticasone Propionate	96	33
Simvastatin	Simvastatin	95	28
Rosuvastatin Calcium	Rosuvastatin Calcium	87	28
Tamsulosin Hcl	Tamsulosin Hcl	87	21
Allopurinol	Allopurinol	86	26
Carvedilol	Carvedilol	86	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	25
Pantoprazole Sodium	Pantoprazole Sodium	85	28
Sertraline Hcl	Sertraline Hcl	85	25
Clonazepam	Clonazepam	83	16
Jardiance	Empagliflozin	79	13
Metoprolol Tartrate	Metoprolol Tartrate	75	18
Trazodone Hcl	Trazodone Hcl	74	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	19
Montelukast Sodium	Montelukast Sodium	69	19
Hydroxyzine Hcl	Hydroxyzine Hcl	68	12
Tizanidine Hcl	Tizanidine Hcl	68	27
Ondansetron Hcl	Ondansetron Hcl	67	20
Duloxetine Hcl	Duloxetine Hcl	66	13
Venlafaxine Hcl Er	Venlafaxine Hcl	63	12
Pravastatin Sodium	Pravastatin Sodium	60	15
Glipizide	Glipizide	58	14
Warfarin Sodium	Warfarin Sodium	55	17
Synthroid	Levothyroxine Sodium	54	11
Clopidogrel	Clopidogrel Bisulfate	53	11
Citalopram Hbr	Citalopram Hydrobromide	52	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	51	12
Alendronate Sodium	Alendronate Sodium	50	16
Valsartan	Valsartan	50	12
Famotidine	Famotidine	48	18
Potassium Chloride	Potassium Chloride	48	15
Diclofenac Sodium	Diclofenac Sodium	47	16
Oxycodone Hcl	Oxycodone Hcl	47	14
Lorazepam	Lorazepam	46	suppressed
Celecoxib	Celecoxib	45	suppressed
Glipizide Er	Glipizide	45	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Pregabalin	Pregabalin	43	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Spironolactone	Spironolactone	42	12
Prednisone	Prednisone	41	32
Zolpidem Tartrate	Zolpidem Tartrate	41	12
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Glimepiride	Glimepiride	36	suppressed
Tresiba Flextouch U-200	Insulin Degludec	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Ezetimibe	Ezetimibe	34	11
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Nystatin	Nystatin	31	15
Atenolol	Atenolol	30	suppressed
Baclofen	Baclofen	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	12
Azelastine Hcl	Azelastine Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	18
Januvia	Sitagliptin Phosphate	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Meloxicam	Meloxicam	26	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Naproxen	Naproxen	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Estradiol	Estradiol	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Fluconazole	Fluconazole	21	17
Ibu	Ibuprofen	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Xarelto	Rivaroxaban	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Lidocaine	Lidocaine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Bumetanide	Bumetanide	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Cephalexin	Cephalexin	15	13
Azithromycin	Azithromycin	14	11
Calcitriol	Calcitriol	14	suppressed
Finasteride	Finasteride	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Lovastatin	Lovastatin	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Linzess	Linaclotide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Estradiol (Once Weekly)	Estradiol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Topiramate	Topiramate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error